These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1257 related items for PubMed ID: 34777460

  • 1. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
    Zhao J, Lin X, Zhuang J, He F.
    Front Genet; 2021; 12():714697. PubMed ID: 34777460
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Construction of a Novel Signature and Prediction of the Immune Landscape in Soft Tissue Sarcomas Based on N6-Methylandenosine-Related LncRNAs.
    Zhang L, Tang X, Wan J, Zhang X, Zheng T, Lin Z, Liu T.
    Front Mol Biosci; 2021; 8():715764. PubMed ID: 34733885
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
    Ma T, Wang X, Meng L, Liu X, Wang J, Zhang W, Tian Z, Zhang Y.
    BMC Cancer; 2021 Nov 21; 21(1):1256. PubMed ID: 34802433
    [Abstract] [Full Text] [Related]

  • 7. N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients.
    Zhang P, Liu G, Lu L.
    Front Cell Dev Biol; 2021 Nov 21; 9():703629. PubMed ID: 34336856
    [Abstract] [Full Text] [Related]

  • 8. Prognostic Value of N6-Methyladenosine-Related lncRNAs in Early-Stage Colorectal Cancer: Association With Immune Cell Infiltration and Chemotherapeutic Drug Sensitivity.
    Xiong Z, Li X, Yin S, Xie M, Mao C, Zhang F, Chen H, Jin L, Lian L.
    Front Mol Biosci; 2021 Nov 21; 8():724889. PubMed ID: 34712696
    [Abstract] [Full Text] [Related]

  • 9. N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients.
    Tu Z, Wu L, Wang P, Hu Q, Tao C, Li K, Huang K, Zhu X.
    Front Cell Dev Biol; 2020 Nov 21; 8():642. PubMed ID: 32793593
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification.
    Gao C, Kong N, Zhang F, Tang T, Li J, Ding H, Sun Z, Wu L, Xu M.
    BMC Med Genomics; 2022 Jan 29; 15(1):15. PubMed ID: 35093068
    [Abstract] [Full Text] [Related]

  • 12. Integrated Analyses Reveal Potential Functional N6-Methyladenosine-Related Long Noncoding RNAs in Adrenocortical Adenocarcinoma.
    Ding Y, Wang T, Feng Y, Ding X, Li X, Huang Z, Jia Z, Wang J, Yang J.
    Front Cell Dev Biol; 2022 Jan 29; 10():851748. PubMed ID: 35669515
    [Abstract] [Full Text] [Related]

  • 13. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y, Zhu GQ, Tian D, Zhou CW, Li N, Feng Y, Zeng MS.
    BMC Cancer; 2022 Mar 24; 22(1):316. PubMed ID: 35331183
    [Abstract] [Full Text] [Related]

  • 14. N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma.
    Hu Y, Chen Y.
    Sci Rep; 2021 Sep 08; 11(1):17844. PubMed ID: 34497315
    [Abstract] [Full Text] [Related]

  • 15. N-6 methylation-related lncRNA is potential signature in lung adenocarcinoma and influences tumor microenvironment.
    Zheng J, Zhao Z, Wan J, Guo M, Wang Y, Yang Z, Li Z, Ming L, Qin Z.
    J Clin Lab Anal; 2021 Nov 08; 35(11):e23951. PubMed ID: 34558724
    [Abstract] [Full Text] [Related]

  • 16. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
    Yang K, Wang F, Li K, Peng G, Yang H, Xu H, Xiang Y, Sun H.
    Technol Cancer Res Treat; 2022 Nov 08; 21():15330338221085354. PubMed ID: 35422168
    [Abstract] [Full Text] [Related]

  • 17. N6-Methyladenosine-Related Long Non-coding RNA Signature Associated With Prognosis and Immunotherapeutic Efficacy of Clear-Cell Renal Cell Carcinoma.
    Ma T, Wang X, Wang J, Liu X, Lai S, Zhang W, Meng L, Tian Z, Zhang Y.
    Front Genet; 2021 Nov 08; 12():726369. PubMed ID: 34721523
    [Abstract] [Full Text] [Related]

  • 18. Tumor necrosis factor-related lncRNAs predict prognosis and immunotherapy response for patients with lung adenocarcinoma.
    Chen JH, Wu X, Wang ZM, Liu ZY, He BX, Song WP, Zhang WZ.
    J Thorac Dis; 2023 Mar 31; 15(3):1373-1386. PubMed ID: 37065578
    [Abstract] [Full Text] [Related]

  • 19. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
    Song W, Ren J, Yuan W, Xiang R, Ge Y, Fu T.
    Genes (Basel); 2021 Aug 31; 12(9):. PubMed ID: 34573357
    [Abstract] [Full Text] [Related]

  • 20. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients.
    Wang JM, Li X, Yang P, Geng WB, Wang XY.
    BMC Gastroenterol; 2022 Feb 21; 22(1):76. PubMed ID: 35189810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.